AACE is closely monitoring developments regarding COVID-19 and working with partner medical societies to provide information and resources to our members. Please refer to the links below:
Medicare will temporarily pay clinicians to provide telehealth services for beneficiaries across the entire country. Read more.
AMA's Quick Guide to Telemedicine in Practice
ACP's COVID-19 Telehealth Coding and Billing Practice Management Tips
COVID-19 Telehealth HIPAA Information from HHS.gov
CMS's Medicare Telemedicine Health Care Provider Fact Sheet
AACE Member Gregory Dodell, MD, FACE, has created a helpful presentation detailing how to set up and operate your telemed service. View the presentation below, and follow @DodellMD on Twitter for more tips.
Telemedicine SOAPRUNTIME: 12:56
Watch Dr. Dodell explain the set-up, operation, action and plan/policy for your practice's telemedicine service.
Read this special report by AACE members Gauri Behari, MD, Karyne Vinales, MD, and Ricardo Correa MD, Es.D, who share their experience with telemedicine tools both before and after the COVID-19 health crisis.
Help your patients prepare for their telemedicine visit by reading "Telemedicine Checklist: 3 Steps to Prepare for Your Virtual Visit."
Read the Endocrine Practice article, "Telehealth Adoption Among Endocrinologists During COVID-19 Pandemic"
Read AACE's media outreach efforts and the efforts of our partners to help keep our patients safe.
AACE Position Statement (April 15): Coronavirus (COVID-19) and People with Cardiometabolic Disease
AACE Position Statement (April 15): Coronavirus (COVID-19) and People with Thyroid Disease
AACE Position Statement (March 24): Coronavirus (COVID-19) and People with Adrenal Insufficiency and Cushing’s Syndrome
AACE Position Statement (March 18): Coronavirus (COVID-19) and People with Diabetes
AACE Position Statement (March 9): Coronavirus (COVID-19) and People with Diabetes
AACE President Sandra Weber, MD, FACP, FACE spoke with The New York Times in their piece entitled,
"Coronavirus Threatens Americans With Underlying Conditions"
Read recent studies related to COVID-19 published in our journal"Endocrine Practice"
Learn more about the relationship between COVID-19 and Obesity from the STOP Obesity Alliance
New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S.
Abbott’s Freestyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic
Xeris Pharmaceuticals Extends $0 Copay for Gvoke PFS for People with Diabetes Through May 31
Novo Nordisk offers free 90-day insulin supply to people experiencing financial hardship due to COVID-19
Sanofi bolsters patient access due to COVID-19
Amgen has asked health care providers to supply these Temporary Self-Administration Instructions for Use to their patients who cannot receive prescribed Prolia injections by their health care provider due to constraints during the COVID-19 pandemic. Administration of Prolia by a healthcare provider remains the preferred mode of administration where possible. These instructions are for use only during the COVID-19 public health emergency declared by the Secretary of Health and Human Services on January 31, 2020. They should be discarded following the public health emergency. Patients can also view this demonstration video to aid in self-administration.